Free Trial
NASDAQ:INMD

InMode Q2 2026 Earnings Results & Report

InMode logo
$14.22 -0.09 (-0.63%)
As of 10:20 AM Eastern
This is a fair market value price provided by Massive. Learn more.

InMode beat analyst expectations on both earnings and revenue in its Q2 2026 results, released August 5, 2026. The company reported EPS of $0.35 versus the $0.3460 consensus estimate, while revenue of $95.59 million topped the $94.89 million estimate by $0.70 million.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens
Conference Call
9:30 AM ET

InMode EPS Results

Actual EPS
$0.35
Consensus EPS
$0.3460
Beat/Miss
Beat by +$0.0040
One Year Ago EPS
$0.47
EPS Beat Rate
4 of last 8 quarters

InMode Revenue Results

Actual Revenue
$95.59 million
Expected Revenue
$94.89 million
Beat/Miss
Beat by +$698.00 thousand
YoY Revenue Growth
N/A

Upcoming Earnings

InMode's Q3 2026 earnings is estimated for Wednesday, October 28, 2026, based on past reporting schedules

Earnings Documents

InMode Q2 2026 Earnings FAQ

InMode (NASDAQ:INMD) reported earnings of $0.35 per share for Q2 2026, beating the consensus estimate of $0.3460. The report was announced on Wednesday, August 5, 2026.

InMode reported revenue of $95.59 million for Q2 2026, against a consensus estimate of $94.89 million.

InMode's next earnings date is estimated for Wednesday, October 28, 2026. MarketBeat tracks confirmed and estimated earnings dates for InMode on the company's earnings history page.

InMode Earnings Headlines

InMode Sees Up to $92 Million in Q3 Revenue; Shares Up Pre-Bell
The Iran War Isn’t Chaos. It’s Strategy.
Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congressmen no cameras, no staff. What he found afterward points to a coordinated Two-Front Economic War already in motion, according to his research at Behind the Markets.tc pixel
InMode Ltd. (NASDAQ:INMD) Stock Has Average Price Target of $16.00
See More InMode Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like InMode? Sign up for Earnings360's daily newsletter to receive timely earnings updates on InMode and other key companies, straight to your email.

About InMode

InMode (NASDAQ:INMD) is an Israel-based medical technology company that develops, manufactures and markets energy-based platforms for aesthetic and medical treatments. Its technologies are designed to support minimally invasive and noninvasive procedures in areas such as skin rejuvenation, facial and body contouring, hair removal, intimate health and other soft-tissue applications.

The company’s product portfolio includes radiofrequency and other energy-based systems sold under brands such as Morpheus8, BodyTite, FaceTite, Forma and Lumecca. These platforms are used by physicians and other medical professionals in dermatology, plastic surgery and aesthetic practices, with applications that may include tissue remodeling, skin tightening, fat reduction and treatment of skin conditions.

InMode sells its products internationally through a combination of direct sales and distributors, serving customers in North America, Europe, Asia-Pacific, Latin America and other markets. The company was founded in 2008 and is headquartered in Yokneam, Israel. InMode became a publicly traded company on the Nasdaq in 2019 and has been led by co-founder Moshe Mizrahy, who serves as chief executive officer.

View InMode Profile